Sangamo Biosciences (SGMO), Shire (SHPG) Revise ZFP Therapeutics Development Agreement
Tweet Send to a Friend
Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that the company and its collaborator, Shire plc (Nasdaq: SHPG), have agreed to revise ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
